A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.

NCT05689164 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped All participants who have received fordadistrogene movaparvovec in any Pfizer study will now be assessed for long-term safety in 1 combined study: C3391003

Conditions

Interventions

Sponsor

Pfizer